X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
alzheimer's disease (72) 72
medical and health sciences (68) 68
medicin och hälsovetenskap (68) 68
neurology (54) 54
clinical medicine (53) 53
klinisk medicin (53) 53
neurologi (45) 45
dementia (43) 43
humans (41) 41
neurosciences (35) 35
aged (34) 34
female (34) 34
index medicus (34) 34
male (33) 33
cerebrospinal fluid (25) 25
mild cognitive impairment (22) 22
biomarkers (21) 21
clinical neurology (21) 21
cognition (17) 17
aged, 80 and over (16) 16
amyloid (16) 16
neurovetenskaper (16) 16
middle aged (15) 15
tau (15) 15
dietary supplements (14) 14
alzheimer’s disease (13) 13
apoe (13) 13
omega-3 fatty acids (13) 13
disease progression (12) 12
docosahexaenoic acid (12) 12
alzheimers-disease (11) 11
brain (11) 11
dha (11) 11
epa (11) 11
fatty acids (11) 11
inflammation (11) 11
magnetic resonance imaging (11) 11
neuropsychological tests (11) 11
prognosis (11) 11
alzheimers disease (10) 10
analysis (10) 10
biomarkers - cerebrospinal fluid (10) 10
double-blind method (10) 10
geriatrics (10) 10
geriatrik (10) 10
prevalence (10) 10
alzheimer disease - drug therapy (9) 9
neurodegenerative diseases (9) 9
tau protein (9) 9
alzheimer disease - cerebrospinal fluid (8) 8
csf (8) 8
diagnostic-criteria (8) 8
medicin (8) 8
national institute (8) 8
neurodegeneration (8) 8
psychiatry (8) 8
age (7) 7
alzheimer disease - blood (7) 7
alzheimer disease - diet therapy (7) 7
amyloid-beta (7) 7
association (7) 7
association workgroups (7) 7
diagnostic guidelines (7) 7
fatty acids, omega-3 - administration & dosage (7) 7
geriatrics & gerontology (7) 7
geriatrics and gerontology (7) 7
lipids (7) 7
medical research (7) 7
medicine (7) 7
mri (7) 7
progression (7) 7
recommendations (7) 7
risk (7) 7
studies (7) 7
alzheimer disease - metabolism (6) 6
apolipoproteins e - genetics (6) 6
basic medicine (6) 6
decline (6) 6
eicosapentaenoic acid (6) 6
fatty acids, omega-3 - blood (6) 6
guidelines (6) 6
impairment (6) 6
medicine, experimental (6) 6
medicinska och farmaceutiska grundvetenskaper (6) 6
mental disorders (6) 6
nutrition (6) 6
pathology (6) 6
patients (6) 6
positron-emission tomography (6) 6
psychiatry and mental health (6) 6
research (6) 6
risk factors (6) 6
treatment outcome (6) 6
vascular dementia (6) 6
agitation (5) 5
alzheimer disease - diagnosis (5) 5
alzheimer disease - diagnostic imaging (5) 5
alzheimer disease - physiopathology (5) 5
alzheimer disease - psychology (5) 5
amyloid beta-peptides - cerebrospinal fluid (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Neurology, ISSN 1474-4422, 2009, Volume 8, Issue 7, pp. 619 - 627
Journal Article
The American Journal of Clinical Nutrition, ISSN 0002-9165, 10/2017, Volume 106, Issue 4, pp. 1157 - 1165
Abstract Background: Dietary fish oils, rich in long-chain n–3 (ω-3) fatty acids (FAs) [e.g., docosahexaenoic acid (DHA, 22:6n–3) and eicosapentaenoic acid... 
DNA methylation | LINE-1 | DHA | Alzheimer disease | Fish oil | EPA | fish oil | DIETARY SUPPLEMENTATION | MONONUCLEAR-CELLS | RANDOMIZED CONTROLLED-TRIAL | LIPID MEDIATORS | FISH-OIL SUPPLEMENTATION | NUTRITION & DIETETICS | DOCOSAHEXAENOIC ACID | GENE-EXPRESSION | ALZHEIMERS-DISEASE PATIENTS | OMEGA-3-FATTY-ACID SUPPLEMENTATION | EICOSAPENTAENOIC ACID | Leukocytes, Mononuclear - metabolism | Apolipoprotein E4 - metabolism | Double-Blind Method | Humans | Alzheimer Disease - drug therapy | Male | Fish Oils - blood | Fish Oils - pharmacology | Docosahexaenoic Acids - pharmacology | Eicosapentaenoic Acid - blood | Docosahexaenoic Acids - blood | Eicosapentaenoic Acid - pharmacology | Time Factors | Long Interspersed Nucleotide Elements | Alzheimer Disease - metabolism | Aged, 80 and over | CpG Islands | Female | Aged | Inflammation - prevention & control | Fatty Acids - blood | DNA Methylation - drug effects | Dietary Supplements | Post-translational modification | Diet therapy | Dietary supplements | Genetic aspects | Leukocytes | Methylation | Health aspects | Alzheimer's disease | Omega-3 fatty acids | Neurologi | Medical and Health Sciences | Hematology | Medicin och hälsovetenskap | Hälsovetenskaper | Klinisk medicin | Näringslära | Clinical Medicine | Neurology | Hematologi | Nutrition and Dietetics | Health Sciences
Journal Article
American Journal of Clinical Nutrition, ISSN 0002-9165, 06/2008, Volume 87, Issue 6, pp. 1616 - 1622
Journal Article
The Lancet Neurology, ISSN 1474-4422, 12/2017, Volume 16, Issue 12, pp. 965 - 975
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 2017, Volume 55, Issue 4, pp. 1417 - 1427
Background: The search for a biomarker of Alzheimer's disease (AD) pathology (amyloid-β (Aβ) and tau) is ongoing, with the best markers currently being... 
tau | Psychiatry and Mental health | Clinical Psychology | biomarker | Alzheimer's disease | blood | multi-modal | polygenic risk score | Geriatrics and Gerontology | CRITERIA | SCORE | ALZHEIMERS-DISEASE | LOCI | NEUROSCIENCES | SWEDISH TWINS | PREDICTION | BIOMARKERS | Oligonucleotide Array Sequence Analysis | Humans | Databases, Factual - statistics & numerical data | Logistic Models | Male | Positron-Emission Tomography | tau Proteins - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | tau Proteins - blood | Apolipoproteins E - genetics | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Polymorphism, Single Nucleotide - genetics | Female | Aged | Alzheimer Disease - diagnostic imaging | Biomarkers - cerebrospinal fluid | Alzheimer Disease - genetics | Early Diagnosis | Cohort Studies | Failure rates | Neuroimaging | Brain | Cerebrospinal fluid | Blood | Oligomers | Demographics | Apolipoprotein E | Tomography | Dementia disorders | Mathematical models | Genotypes | Predictive control | Medical imaging | Neurodegenerative diseases | Positron emission | Regression analysis | Model accuracy | Studies | Pathology | Neurology | Screening | Tau protein | Biomarkers | β-Amyloid | Risk management | Health risk assessment | Positron emission tomography | Basic Medicine | Neurosciences | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Neurovetenskaper
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2012, Volume 7, Issue 4, p. e35425
Background: Dietary fish oil, rich in n-3 fatty acids (n-3 FAs), e. g. docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), regulate inflammatory... 
FISH-OIL SUPPLEMENTATION | COLON-CANCER CELLS | TUMOR-NECROSIS-FACTOR | CYTOKINE PRODUCTION | ALZHEIMERS-DISEASE | BIOLOGY | SORTING PROTEIN | OMEGA-3-FATTY-ACID DOCOSAHEXAENOIC ACID | RECEPTOR | RISK | NF-KAPPA-B | Docosahexaenoic Acids - therapeutic use | Leukocytes, Mononuclear - metabolism | Humans | Gene Expression Regulation | Transcriptome | Male | Eicosapentaenoic Acid - blood | Alzheimer Disease - diet therapy | Docosahexaenoic Acids - blood | Aged, 80 and over | Fatty Acids, Omega-3 - therapeutic use | Fatty Acids, Omega-3 - blood | Female | Aged | Eicosapentaenoic Acid - therapeutic use | Alzheimer Disease - genetics | Dietary Supplements | Medical research | Genes | Genomics | Dietary supplements | Genomes | Research | Gene expression | Unsaturated fatty acids | DNA microarrays | Analysis | Medicine, Experimental | Alzheimer's disease | Omega-3 fatty acids | Health care | Neurosciences | Transplants & implants | Neurobiology | Leukocytes (mononuclear) | Cardiovascular disease | Leukocytes | Docosahexaenoic acid | Blood | Transgenic animals | Neurodegeneration | Rodents | Peripheral blood mononuclear cells | Tumor necrosis factor-TNF | Supplementation | Drug dosages | Public health | Cytokines | Fish oils | Neurodegenerative diseases | CD63 antigen | Inflammation | Patients | Fatty acids | Disease control | Studies | White blood cells | Nutrition research | Hospitals | Diet | Womens health | Fats and oils | Alzheimers disease | Eicosapentaenoic acid | Basic Medicine | Medical Genetics | Medicinsk genetik | Clinical Medicine | Medical and Health Sciences | Hematology | Hematologi | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Klinisk medicin
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 05/2019, Volume 69, Issue 1, pp. 189 - 197
Background: Trials of supplementation with omega-3 fatty acids (ω3-FAs) in patients with mild cognitive impairment or Alzheimer’s disease (AD) have produced... 
Brain | Cognitive ability | Medical services | Clinical trials | Cognition | Docosahexaenoic acid | Fatty acids | Patients | Atrophy | Cognition & reasoning | Vitamin B | Supplementation | Homocysteine | Eicosapentaenoic acid | Alzheimer's disease
Journal Article
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 03/2017, Volume 57, Issue 2, pp. 387 - 393
Background: Treatment for neuropsychiatric symptoms (NPS) in dementia is insufficient. Antipsychotics and acetylcholinesterase inhibitors are used generating... 
Appetite | Neuroleptics | Galantamine | Neurodegenerative diseases | Mental disorders | Medical treatment | Eating disorders | Medical services | Cognition | Cerebrospinal fluid | Acetylcholinesterase | Patients | Reduction | Tau protein | Dementia disorders | Biomarkers | Secondary analysis | Risperidone | Alzheimer's disease | Dementia
Journal Article
International Journal of Geriatric Psychiatry, ISSN 0885-6230, 02/2008, Volume 23, Issue 2, pp. 161 - 169
Journal Article
Brain, ISSN 0006-8950, 05/2015, Volume 138, Issue 5, pp. 1327 - 1338
Journal Article